Mercer Global Advisors Inc United Therapeutics Corp Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 15,343 shares of UTHR stock, worth $5.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,343

Previous 13,918 10.24%

Holding current value

$5.72 Million

Previous $4.43 Million 24.02%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$311.04 - $363.55 $443,232 - $518,058	1,425 Added 10.24%	15,343 $5.5 Million
Q2 2024 Aug 12, 2024	BUY	$228.26 - $319.04 $459,487 - $642,227	2,013 Added 16.91%	13,918 $4.43 Million
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $79,456 - $94,065	-377 Reduced 3.07%	11,905 $2.74 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $28,149 - $33,659	131 Added 1.08%	12,282 $2.7 Million
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $473,841 - $555,312	2,237 Added 22.56%	12,151 $2.75 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $191,442 - $217,379	933 Added 10.39%	9,914 $2.19 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $150,370 - $194,976	706 Added 8.53%	8,981 $2.01 Million
Q4 2022 Feb 08, 2023	SELL	$205.95 - $280.43 $8,032 - $10,936	-39 Reduced 0.47%	8,275 $2.3 Million
Q3 2022 Nov 15, 2022	SELL	$203.3 - $244.17 $18,703 - $22,463	-92 Reduced 1.09%	8,314 $1.74 Million
Q2 2022 Aug 10, 2022	SELL	$174.81 - $241.14 $2,272 - $3,134	-13 Reduced 0.15%	8,406 $1.98 Million
Q1 2022 May 10, 2022	SELL	$166.16 - $213.96 $213,515 - $274,938	-1,285 Reduced 13.24%	8,419 $1.51 Million
Q4 2021 Feb 04, 2022	BUY	$184.32 - $216.08 $96,583 - $113,225	524 Added 5.71%	9,704 $2.1 Million
Q3 2021 Nov 10, 2021	BUY	$179.86 - $214.88 $60,972 - $72,844	339 Added 3.83%	9,180 $1.69 Million
Q2 2021 Aug 10, 2021	BUY	$170.47 - $211.93 $147,967 - $183,955	868 Added 10.89%	8,841 $1.59 Million
Q1 2021 May 11, 2021	BUY	$153.94 - $174.85 $444,732 - $505,141	2,889 Added 56.83%	7,973 $1.33 Million
Q4 2020 Feb 12, 2021	BUY	$101.87 - $151.79 $220,956 - $329,232	2,169 Added 74.41%	5,084 $772,000
Q3 2020 Dec 10, 2020	BUY	$99.9 - $121.13 $21,178 - $25,679	212 Added 7.84%	2,915 $294,000
Q2 2020 Aug 10, 2020	BUY	$92.74 - $125.82 $250,676 - $340,091	2,703 New	2,703 $327,000
Q1 2020 May 18, 2020	SELL	$79.39 - $115.35 $610,985 - $887,733	-7,696 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$78.31 - $95.34 $62,804 - $76,462	802 Added 11.63%	7,696 $678,000
Q3 2019 Nov 12, 2019	BUY	$74.85 - $85.99 $156,810 - $180,149	2,095 Added 43.65%	6,894 $549,000
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $31,184 - $49,532	410 Added 9.34%	4,799 $375,000
Q1 2019 Apr 23, 2019	BUY	$107.15 - $126.84 $470,281 - $556,700	4,389 New	4,389 $515,000

Others Institutions Holding UTHR

# of Institutions

669

Shares Held

42.8M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc United Therapeutics Corp Transaction History